Перевести на Переведено сервисом «Яндекс.Перевод»

Imprimis Pharmaceuticals Inc.

Link
imprimispharma.com
Country
USA
Headquarters
12264 El Camino Real, Suite 350 San Diego, CA 92130
Ticker
NASDAQ:IMMY
Description

Imprimis Pharmaceuticals, Inc. (Imprimis) is a pharmaceutical company. The Company focuses on developing and commercializing compounded drug therapies and making these therapies available to physicians and patients. It owns, markets and sells a portfolio of combination formulations in ophthalmology and urology. Its ophthalmology formulation portfolio includes Dropless Therapy and LessDrops formulations, which serve the eye drop market. Its Defeat IC campaign includes a compounded formulation for patients suffering from interstitial cystitis. It makes, dispenses and sells its compounded formulations, as well as other non-proprietary products, through its compounding pharmacies Pharmacy Creations, LLC (Pharmacy Creations) and Park. Its pharmacies also dispense prescriptions for complementary compounded formulations within the ophthalmology and urology therapeutic areas, as well as other compounded formulations in other therapeutic areas for an individually identified patient.